Breast Intraductal Papillomas Without Atypia in Radiologic- Pathologic Concordant Core-Needle Biopsies: Rate of Upgrade to Carcinoma at Excision
|
|
- Rosamund Andrews
- 6 years ago
- Views:
Transcription
1 Breast Intraductal Papillomas Without Atypia in Radiologic- Pathologic Concordant Core-Needle Biopsies: Rate of Upgrade to Carcinoma at Excision Fresia Pareja, MD, PhD 1 ; Adriana D. Corben, MD 1 ; Sandra B. Brennan, MB 2 ; Melissa P. Murray, DO 1 ; Zenica L. Bowser, MS 1 ; Kiran Jakate, MD 3 ; Christopher Sebastiano, MD 1 ; Monica Morrow, MD 4 ; Elizabeth A. Morris, MD 2 ; and Edi Brogi, MD, PhD 1 BACKGROUND: The surgical management of mammary intraductal papilloma without atypia (IDP) identified at core-needle biopsy (CNB) is controversial. This study assessed the rate of upgrade to carcinoma at surgical excision (EXC). METHODS: This study identified women with a CNB diagnosis of intraductal papilloma without atypia or carcinoma at a cancer center between 2003 and Radiologic-pathologic concordance was assessed for all cases, and discordant cases were excluded. The radiologic and clinicopathologic features of patients with a CNB diagnosis of IDP were correlated with an upgrade to carcinoma at EXC. RESULTS: The study population consists of 189 women with 196 IDPs; 166 women (171 IDPs) underwent EXC. The upgrade rate was 2.3% (4 of 171). The upgraded lesions were 2 invasive lobular carcinomas and 2 cases of ductal carcinoma in situ (DCIS). One case of DCIS involved the residual IDP, whereas the other 3 carcinomas were 8 mm away. Twenty-four women (25 IDPs) did not undergo EXC and had stable imaging on follow-up (median, 23.5 months). CONCLUSIONS: The upgrade rate at EXC for IDPs diagnosed at CNB with radiologicpathologic concordance was 2.3%. These findings suggest that observation is appropriate for patients with radiologic-pathologic concordant CNB yielding IDP, regardless of its size. Cancer 2016;122: VC 2016 American Cancer Society. KEYWORDS: atypia, biopsy, breast, carcinoma, core needle, excision, papilloma, upgrade. INTRODUCTION The standard of care for the management of atypical papilloma at core-needle biopsy (CNB) is surgical excision (EXC) because numerous studies have demonstrated high rates of upgrade to carcinoma. 1-5 Surgical management after a CNB diagnosis of intraductal papilloma without atypia (IDP), however, remains controversial. EXC of all IDPs is recommended by most investigators because of the high reported rates of upgrade in some series 6-8 and the inability of imaging studies to accurately classify the lesions. 9 However, most of the published series did not take into account radiologic-pathologic concordance of the lesions, 10 which may lead to falsely high upgrade rates. The integrated evaluation of imaging and CNB histological findings directs the management of patients with breast lesions, and radiologic-pathologic discordant findings always mandate EXC. 11 A few recent series found low upgrade rates at EXC of lesions yielding IDP at CNB, 12,13 and the investigators concluded that EXC is not required and that imaging surveillance is sufficient. A number of radiologic and histologic features predictive of upgrade have been suggested; they include a size 1.5 mm on imaging, 14 the presence of microcalcifications, 13 and older patient age. 15 This study was aimed at determining the upgrade rate at EXC of IDP diagnosed at CNB in a large series of cases with radiologic-pathologic concordance and at identifying clinical, histologic, or radiologic variables predictive of an upgrade at EXC. Corresponding author: Edi Brogi, MD, PhD, Department of Pathology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065; Fax: (929) ; brogie@mskcc.org 1 Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York; 2 Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York; 3 Department of Pathology, St. Michael s Hospital, Toronto, Ontario, Canada; 4 Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York We thank Patrick Hilden (Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center) for his comments on the statistical evaluation of this study. F.P. and A.D.C. contributed equally to this article. Additional supporting information may be found in the online version of this article DOI: /cncr.30118, Received: January 15, 2016; Revised: April 21, 2016; Accepted: May 2, 2016, Published online June 17, 2016 in Wiley Online Library (wileyonlinelibrary.com) Cancer September 15,
2 MATERIALS AND METHODS Identification of Cases The institutional review board approved this study. A computerized search of the pathology department database identified 385 women who underwent CNB of a breast lesion at our center between July 2003 and December 2013 and received a diagnosis of papilloma. We excluded from the study 155 patients who had carcinoma in the CNB material, had no slides available for review, or underwent EXC at another institution and 12 patients who did not undergo EXC and had no follow-up imaging at our institution. We conducted a pathology review of 218 cases and excluded 7 cases of papillary usual ductal hyperplasia and 12 atypical papillomas or IDPs with adjacent atypia in the CNB material. Three radiologicpathologic discordant cases were also excluded. Clinical information, including the sex, race, age at diagnosis, symptoms, and personal history of breast carcinoma, was retrieved from the electronic medical records. Radiology Review and CNB Procedure A breast radiologist (S.B.) reviewed all available preand post-cnb imaging studies and assessed the size of the lesion and its distance from the nipple, the indication for biopsy (calcifications, mass, nonmass enhancement [NME], and asymmetry), and the presence of a residual target after CNB. The distribution and morphology of calcifications, the shape and margins of masses, and the pattern of NME were noted. Lesion enhancement kinetics were evaluated. The mode of biopsy, biopsy modality, needle gauge, and number of tissue cores were recorded. Pathology Review Review of CNB material Two breast pathologists (A.D.C. and F.P.), blinded to the EXC diagnosis, reviewed the hematoxylin and eosin slides of all CNB cases included in the study. Lesions consisting of arborizing fibrovascular cores lined by epithelium and myoepithelium were categorized as intraductal papillomas, 16 and they were further classified according to the presence of epithelial atypia as either IDP or atypical papilloma. Cases showing atypical papilloma, a high-risk lesion (ie, atypia, lobular carcinoma in situ, or radial scar), or papillary usual ductal hyperplasia in the CNB material were excluded from the study. We assessed the histologic features of the IDPs, including the size (the greatest dimension in a single core), complete removal at CNB, fragmentation, and associated calcifications. Review of surgical excision specimens The hematoxylin and eosin slides of all EXC specimens were reviewed to assess the presence of residual IDP and its size as well as the biopsy site, atypia, and carcinoma. The nature of the atypia or high-risk lesion, along with its spatial relation with the residual IDP or biopsy site, was annotated. An upgrade was defined as the presence of invasive carcinoma and/or ductal carcinoma in situ (DCIS) in the EXC specimen. We recorded the characteristics of the carcinoma (tumor type, size, and histologic grade) and its spatial relation with the residual IDP. The slides of CNB and EXC specimens of the cases with upgrades were also reviewed together by 2 additional breast pathologists (E.B. and M.M.). Statistical Analysis Statistical analysis was performed with IBM SPSS Statistics for Windows (version 22.0; IBM, Armonk, NY). Fisher s exact text was used to assess the association of categorical variables with an upgrade; one-way analysis of variance (one-way ANOVA) was used to evaluate continuous variables. Statistical significance was defined as a P value <.05. Because of the small number of cases upgraded to carcinoma on EXC (n 5 4), a correction of P values for multiple comparisons was not performed. For patients with more than 1 IDP, the analysis of the radiologic and histopathologic features was based on the number of CNBs and IDPs. The analysis of the clinical characteristics was performed per patient. For 1 patient with bilateral metachronous IDPs, we used the age at the time of the first diagnosis of IDP for the analysis. RESULTS Patient Characteristics The study population consisted of 189 women with a CNB diagnosis of IDP (183 patients had 1 IDP, 5 had 2 IDPs, and 1 had 3 IDPs). The total number of IDPs was 196. The mean patient age at diagnosis was years (range, years). Most women (n 5 166) underwent EXC of the radiologic target lesion. Twenty-four women did not undergo EXC but were followed clinically and radiologically. One woman underwent EXC of 2 synchronous IDPs but did not undergo EXC of a third IDP, which was detected 2 years later. Patients Who Underwent Surgical Excision Clinical characteristics One hundred sixty-six patients with 171 IDPs underwent EXC. The mean age was years (range, years); 89 patients (53.6%) were 50 years old. Most 2820 Cancer September 15, 2016
3 Non-atypical Papillomas Can Be Observed/Pareja et al TABLE 1. Clinical Characteristics of the Patients According to the Upgrade Status at Excision Total No Upgrade Upgrade P Patients, No. (%) 166 (100) 162 (100) 4 (100) Age Mean 6 SEM, years Median (range), years 50.5 (25-85) 50 (25-85) 51.5 (50-58) 50 y, No. (%) 89 (53.6) 85 (52.5) 4 (100).124 <50 y, No. (%) 77 (46.4) 77 (47.5) 0 Ethnicity, No. (%) a White 108 (65.5) 105 (65.2) 3 (75).352 African American 38 (23) 38 (23.6) 0 Asian/Indian 11 (6.7) 10 (6.2) 1 (25) Hispanic 8 (4.8) 8 (5) 0 Symptoms, No. (%) No 150 (90.4) 146 (90.1) 4 (100) Yes 16 (9.6) 16 (9.9) 0 Nipple discharge 8 (50) 8 (50) 0 Palpable mass 7 (43.8) 7 (43.8) 0 Pain 1 (6.3) 1 (6.3) 0 Personal history of breast cancer, No. (%) Yes 58 (34.9) 55 (34) 3 (75).123 No 108 (65.1) 107 (66) 1 (25) Concurrent Yes 28 (16.9) 26 (16) 2 (50).133 No 138 (83.1) 136 (84) 2 (50) Concurrent and ipsilateral Yes 12 (7.2) 10 (6.2) 2 (50).027 No 154 (92.8) 152 (93.8) 2 (50) Prior Yes 30 (18.1) 29 (17.9) 1 (25).553 No 136 (81.9) 133 (82.1) 3 (75) Abbreviation: SEM, standard error of the mean. a Information was available for 165 patients. patients (108 or 65.5%) were of white ethnicity, 38 (23%) were African American, 11 (6.7%) were Asian/Indian, and 8 (4.8%) were Hispanic; no information was available for 1 patient. Only 16 women (9.6%), including 8 with nipple discharge, reported symptoms. Fifty-eight patients (34.9%) had either prior (30 or 18.1%) or concurrent breast carcinoma (28 or 16.9%). The latter was ipsilateral in 12 patients (7.2%; Table 1). Radiologic characteristics of the target lesion The mean size of the radiologic target was mm (range, 2-43 mm). In 20 cases (11.8%), the radiologic target measured 15 mm. The mean and median distance between the nipple and the radiologic target were and 30 mm (range, mm), respectively; 109 lesions (64.1%) were > 20 mm from the nipple. The radiologic targets were 102 masses (59.6%), 34 calcifications (19.9%), 33 NMEs (19.3%), and 2 asymmetries (1.2%). The radiologic features were not associated with an upgrade (Table 2 and Supporting Table 1 [see online supporting information]). CNB procedure characteristics Seventy-eight biopsies (45.6%) were ultrasound (US)- guided, 57 (33.3%) were magnetic resonance imaging (MRI) guided, and 36 (21.1%) were stereotactic. One hundred IDPs (58.5%) were sampled by vacuum-assisted biopsy (VAB), and 71 (41.5%) were sampled by automated core-needle biopsy (ACB). The needle gauge ranged from 9 to 18. The median number of cores per procedure was 6 (range, 1-20). The CNB procedure characteristics were not associated with an upgrade (Table 2 and Supporting Table 2 [see online supporting information]). Histopathologic characteristics of IDPs in the CNB samples The mean microscopic size of the IDPs was mm (range, mm); 144 IDPs (84.2%) were 2 mm. Eighty-one IDPs (47.7%) were fragmented, 56 (32.7%) had calcifications, and 20 (11.7%) appeared completely removed at CNB. The mean size of fragmented IDPs ( mm) was greater than the size of nonfragmented IDPs ( mm; P 5.03; Table 3). Cancer September 15,
4 TABLE 2. Radiologic Characteristics of the Target Lesions and Characteristics of the Core-Needle Biopsy Procedure According to the Upgrade Status at Excision Total No Upgrade Upgrade P Target lesions 171 (100) 167 (100) 4 (100) Size a Mean 6 SEM, mm Median (range), mm 7 (2-43) 7 (2-43) 11.5 (3-13) 15 mm, No. (%) 20 (11.8) 20 (12) <15 mm, No. (%) 150 (88.2) 146 (88) 4 (100) 10 mm, No. (%) 54 (31.8) 51 (30.7) 3 (75).095 <10 mm, No. (%) 116 (68.2) 115 (69.3) 1 (25) Distance from nipple a Mean 6 SEM, mm Median (range), mm 30 (10-140) 30 (10-140) 55 (10-70) >20 mm, No. (%) 109 (64.1) 106 (63.9) 3 (75) mm, No. (%) 61 (35.9) 60 (36.1) 1 (25) CNB target lesion, No. (%) Mass 102 (59.6) 100 (59.9) 2 (50).972 Calcifications 34 (19.9) 33 (19.8) 1 (25) NME 33 (19.3) 32 (19.2) 1 (25) Asymmetry 2 (1.2) 2 (1.2) 0 Mode of biopsy, No. (%) US-guided 78 (45.6) 76 (45.5) 2 (50).936 MRI-guided 57 (33.3) 56 (33.5) 1 (25) Stereotactic 36 (21.1) 35 (21) 1 (25) Biopsy modality, No. (%) VAB 100 (58.5) 96 (57.5) 4 (100).142 ACB 71 (41.5) 71 (42.5) 0 Needle gauge Mean 6 SEM Median (range) 11 (9-18) 11 (9-18) 11.5 (9-12) No. of cores b Mean 6 SEM Median (range) 6 (1-20) 6 (1-20) 9 (3-12) Abbreviations: ACB, automated core-needle biopsy; CNB, core-needle biopsy; MRI, magnetic resonance imaging; NME, nonmass enhancement; SEM, standard error of the mean; US, ultrasound; VAB, vacuum-assisted biopsy. a Only 170 cases were evaluable. b Information was available for 153 cases. Histopathologic characteristics of upgraded lesions in surgical excision specimens The upgrade rate to carcinoma (2 invasive lobular carcinomas and 2 cases of DCIS) in the EXC specimen was 2.3% (4 of 171 cases). All carcinomas measured 2 mm. DCIS involved the residual IDP in 1 case (true upgrade). The other 3 carcinomas were at least 0.8 mm from the residual IDP (incidental upgrades; Table 4 and Figs. 1 and 2). Additional histopathologic findings in surgical excision specimens Upon a review of the EXC specimens, the biopsy site was documented in all cases. A residual IDP was present in 107 EXC specimens (62.6%), and the mean histologic size was 5.5 mm (range, mm; Table 3). Thirtynine cases (22.8%) harbored a high-risk lesion (19 cases of atypical ductal hyperplasia, 7 cases of atypical lobular hyperplasia, 4 cases of lobular carcinoma in situ, 1 columnar cell change with atypia, and 8 radial scars) that was not present in the initial CNB sample. Analysis of features predictive of an upgrade Clinical features. The age of patients with and without upgrades was comparable ( vs y, respectively). Concurrent ipsilateral breast carcinoma was the only clinical parameter associated with an upgrade. Two of the 4 patients with an upgrade had concurrent ipsilateral breast carcinoma, whereas only 10 of the 162 patients without an upgrade (6.2%) did. None of the patients with an upgrade was symptomatic (Table 1). Radiologic features and CNB procedure characteristics. There were no statistically significant differences in the radiologic characteristics of the lesions with and without upgrade. The radiologic target of CNB was a mass in 2 of the 4 cases with an upgrade (50%) and in 100 cases (59.9%) without an upgrade. In 2 cases with an upgrade, CNB targeted a mass. One mass was oval with circumscribed margins; the other had an irregular shape and was not circumscribed. For the other 2 cases with an upgrade at EXC, CNB targeted clustered fine linear calcifications in one case, and linear NME with plateau kinetics in the other. The mean size of the imaging target was similar in cases with an upgrade ( mm) and cases without an upgrade ( mm); no imaging target size threshold correlated with an upgrade. The IDPs were > 20 mm from the nipple in most cases with (3 or 75%) and without an upgrade (106 or 63.9%). All 4 radiologic targets with an upgrade at EXC were sampled with VAB (1 CNB was stereotactic, 2 were USguided, and 1 was MRI-guided). The mean size of the imaging target sampled by VAB ( mm) was significantly greater than the mean size of the lesions sampled by ACB ( mm; P 5.043). The needle gauge in the cases with an upgrade ranged from 9 to 12. None of these parameters were predictive of an upgrade (Table 2 and Supporting Tables 1 and 2 [see online supporting information]). Histopathologic findings. In the CNB material, all IDPs with an upgrade measured 2 mm. The mean size of the IDP was similar for cases with and without an upgrade ( mm; P 5.981). IDP fragmentation was the only histologic parameter associated with an upgrade. All 4 IDPs with an upgrade and 77 of 167 IDPs (46.1%) 2822 Cancer September 15, 2016
5 Non-atypical Papillomas Can Be Observed/Pareja et al TABLE 3. Histopathologic Characteristics of IDPs According to the Upgrade Status at Excision Total No Upgrade Upgrade P IDPs, No. (%) 171 (100) 167 (100) 4 (100) CNB specimens IDP size Mean 6 SEM, mm Median (range), mm 3 (0.4-9) 3 (0.4-9) 3.5 (2-4.5) 2 mm, No. (%) 144 (84.2) 140 (83.8) 4 (100) <2 mm, No. (%) 27 (15.8) 27 (16.2) 0 Complete removal of IDP, No. (%) Yes 20 (11.7) 20 (12) No 151 (88.3) 147 (88) 4 (100) IDP fragmentation, No. (%) Yes 81 (47.4) 77 (46.1) 4 (100).048 No 90 (52.6) 90 (53.9) 0 Calcifications in IDP, No. (%) Yes 56 (32.7) 53 (31.7) 3 (75).103 No 115 (67.3) 114 (68.3) 1 (25) EXC specimens Residual IDP, No. (%) No 64 (37.4) 64 (38.3) Yes 107 (62.6) 103 (61.7) 4 (100) Size Mean 6 SEM, mm Median (range), mm Abbreviations: CNB, core-needle biopsy; EXC, excision; IDP, intraductal papilloma without atypia; SEM, standard error of the mean. without an upgrade were fragmented (P 5.048). Complete IDP removal at CNB and calcifications in the IDP were not associated with an upgrade at EXC. In the EXC specimens, residual IDP was identified in all 4 cases with an upgrade and in 103 cases (61.7%) without an upgrade. The mean sizes of the residual IDPs were similar in the 2 groups (Table 3). Patients Who Did Not Undergo Follow-Up Surgical Excision Twenty-four women with IDP and radiologic-pathologic concordant CNB did not undergo EXC and were followed with imaging studies. The mean age was years (range, y). Three patients (12.5%) had concurrent contralateral breast carcinoma, and none had concurrent ipsilateral breast carcinoma. Two patients (8.3%) had a history of contralateral breast carcinoma. One patient had a longstanding history of spontaneously resolving nipple discharge, which had recurred again and triggered the CNB. The patient chose not to undergo EXC. The mean lesion size by imaging was 7 6 1mm (range, 2-20 mm). The radiologic targets included 13 mass lesions (52%), 9 calcifications (36%), and 3 NME lesions (12%). Ten CNBs (40%) were stereotactic, 8 (32%) were US-guided, and 7 (28%) were MRI-guided. The CNB was VAB in 18 cases (72%) and ACB in 7 cases (28%), with the needle gauge ranging from 9 to 14. A residual post-cnb lesion was noted by imaging in 8 patients (32%). The IDP in the CNB material was fragmented in 5 cases (20%). The median follow-up time was 23.5 months (range, months). A review of follow-up imaging studies showed stability of the lesions and no additional ipsilateral findings. DISCUSSION Although EXC of atypical papillomas identified in a CNB sample is mandated, regardless of radiologic-pathologic concordance, 3 the management of IDPs remains contentious. Many investigators have assessed the upgrade rate of IDP at EXC with conflicting results. In this study, we evaluated a large cohort of patients with IDPs diagnosed with radiologic-pathologic concordant CNB. DCIS or invasive carcinoma was identified in the EXC specimen in 4 of 171 CNBs with a 2.3% rate of upgrading to carcinoma. Our findings confirm that the upgrade rate at EXC of IDP with a radiologic-pathologic concordant CNB sample is low. Swapp et al 12 observed no upgrades in a cohort of 77 radiologic-pathologic concordant IDPs. Moreover, 100 patients with radiologic-pathologic concordant CNB for IDP were stable according to imaging during a mean follow-up time of 36 months. In a series of 85 radiologic-pathologic concordant IDPs, there were 2 upgrades (2.4%), 14 and there were none in a Cancer September 15,
6 TABLE 4. Clinical, Radiologic, and Histopathologic Characteristics of Patients With Upgrade Clinical characteristics Age, years Symptoms No No No No Personal history of breast cancer No Yes (IDC) Yes (IDC) Yes (IDC) Laterality N/A Ipsilateral Ipsilateral Ipsilateral Temporal relationship N/A Prior (24 months) Concurrent Concurrent Radiologic characteristics of target lesion Reason for biopsy Mass NME Mass Calcifications Size, mm Distance from nipple, mm Histopathologic characteristics IDP in CNB specimen Size, mm Completely removed No No No No Fragmented Yes Yes Yes Yes Calcifications in IDP Yes Yes No Yes EXC specimen Upgrade lesion DCIS DCIS ILC ILC Size, mm Grade of invasive carcinoma N/A N/A Mod diff Mod diff DCIS architecture Cribriform Flat and micropapillary N/A N/A DCIS nuclear grade Low Intermediate to high N/A N/A Distance from IDP, mm Involves IDP Residual IDP size, mm Type of upgrade True Incidental Incidental Incidental Abbreviations: CNB, core-needle biopsy; DCIS, ductal carcinoma in situ; EXC, excision; IDC, invasive ductal carcinoma; IDP, intraductal papilloma without atypia; ILC, invasive lobular carcinoma; Mod diff, moderately differentiated; N/A, not applicable; NME, nonmass enhancement. prospective series of 49 cases. 17 Several other smaller series of radiologic-pathologic concordant cases have reported similar findings. 4,18,19 A study of 80 radiologicpathologic concordant IDPs, however, reported an upgrade rate of 18.8%. 20 Notably, 12 of 15 upgrade lesions were papillary carcinomas, and this raises the possibility of undersampling or underdiagnosis at CNB. The latter study did not include MRI-guided CNB. In our series, the upgrade rate without MRI-guided CNB was 2.63% (3 of 114). Rizzo et al 6 reported an upgrade rate of 9% in a study of 234 IDPs. MRI-detected IDPs and IDPs that were <1 to 2 mm in CNB material were excluded from their study. In our series, 27 IDPs (15.8%) measured < 2 mm at CNB, and none were upgraded at EXC. MRI-guided CNB accounted for 57 IDPs (33%), and only 1 had an upgrade at EXC. If we exclude the aforementioned cases, the upgrade rate in our series is 3.2% (3 of 93). Our series includes only radiologic-pathologic concordant cases, whereas Rizzo et al did not specifically indicate radiologic-pathologic concordance as a selection criterion. We studied clinical, radiologic, and histopathologic variables to identify patients with a CNB diagnosis of IDP and a high risk of an upgrade at EXC. Some studies have suggested that age correlates with an upgrade at EXC. 6,21 In our series, age was not significantly related to an upgrade, but all patients with carcinoma were 50 years old. Most patients with an upgrade in the study of Rizzo et al 6 had symptoms, but all of our patients with an upgrade were asymptomatic. Our institution is a cancer center, and a significant percentage of the patients in our study had prior or concurrent breast carcinoma (58 or 34.9%). Ten patients (6.2%) without an upgrade had concurrent ipsilateral breast carcinoma, whereas 2 patients (50%) with an upgrade did (P 5.027). In contrast, Cyr et al 22 found that prior/concurrent breast carcinoma was not associated with atypia or carcinoma at EXC. When worrisome symptoms such as a palpable mass or nipple discharge are present, the need for EXC of a concurrent breast carcinoma should be taken into account in the surgical management of the papilloma. Most patients in our study were of white ethnicity, and 38 (23%) were African American. Li et al 13 studied a population of similar ethnic composition (77% white and 19.5% African American) and reported a 1.9% upgrade rate, which is similar to the rate in our study. In contrast, 70% of the patients in the study by Rizzo et al 6 were African American, and the upgrade rate was higher. It is possible that patient ethnicity correlates with different genetic characteristics and/or differences in access to health care Cancer September 15, 2016
7 Non-atypical Papillomas Can Be Observed/Pareja et al Figure 1. Intraductal papilloma without atypia on core-needle biopsy with an incidental carcinoma in the excision specimen. (A) A minute intraductal papilloma without atypia is present in the core-needle biopsy sample. Inset: No cytologic atypia is evident at a high magnification. (B) The excision specimen contains a 1-mm focus of invasive lobular carcinoma away from (?) the residual intraductal papilloma and (*) the biopsy site. Inset: A close view of the invasive lobular carcinoma is shown. Figure 2. Intraductal papilloma without atypia on core-needle biopsy with a true upgrade to carcinoma. (A) A minute intraductal papilloma without atypia is present in the core-needle biopsy sample. Inset: A magnified view of the intraductal papilloma is shown. (B) The excision specimen contains a 2-mm focus of ductal carcinoma in situ involving (?) the papilloma near (*) the biopsy site. Twenty-six patients (16%) without an upgrade at EXC had concurrent breast carcinoma, whereas 2 patients (50%) with an upgrade did. Even though this variable did not reach statistical significance, possibly because of the low number of upgrades in our study, we believe it prudent to offer IDP EXC to patients with concurrent breast carcinoma. Several efforts have been made to define a radiologic target lesion size threshold predictive of an upgrade, but the results are conflicting. Chang et al 14 reported no upgrades at EXC for IDPs < 15 mm according to imaging. Likewise, Kil et al 2 found that most atypical and malignant papillary lesions measured 15 mm by imaging, whereas most benign papillary lesions were <15 mm. Cancer September 15,
8 Glenn et al, 21 however, described an upgrade rate of 4.7% in IDPs measuring < 15 mm, but they did not report radiologic-pathologic concordance. Other authors have shown that size by imaging is not predictive of an upgrade. 13,21 In our study, the mean imaging sizes of lesions with and without an upgrade were comparable ( vs mm, respectively). None of the lesions with an upgrade was 15 mm; however, 3 of the 4 lesions (75%) were 10 mm, whereas 51 of the 167 lesions (30.7%) without an upgrade were 10 mm. No imaging size threshold was predictive of an upgrade. Altogether, we found that no radiologic feature was significantly associated with an upgrade. Other investigators have also indicated that no mammographic and sonographic findings can distinguish benign papillary lesions from malignant ones, 9 and no radiologic parameter is predictive of carcinoma at EXC. 23 Holley et al 24 reported a lower median number of cores obtained at CNB for IDPs without an upgrade (3; range, 1-7) versus IDPs with an upgrade (5; range, 2-21). The median number of cores in our cohort was 6 (range, 2-16), and this is similar to the median number of cores in a study of 80 IDPs and no upgrades by Wiratkapun et al 25 (6; range, 2-16). In the study by Kim et al, of 131 IDPs (9.2%) sampled by ACB showed an upgrade on EXC, whereas none of 5 IDPs sampled by VAB showed an upgrade on EXC. One hundred IDPs (58.5%) in our study were sampled by VAB. In our series, the biopsy modality did not correlate with an upgrade. It is possible that undersampling might contribute to high upgrade rates in some studies. The histologic size of the IDP in CNB material was not predictive of an upgrade. Jaffer et al 27 reported no upgrades at EXC of incidental papillomas measuring <2 mm, 27 and none of the 27 IDPs spanning < 2mmin CNB material in our series showed an upgrade at EXC. In our series, all 4 IDPs with an upgrade had a histologic size 2 mm at CNB; however, 140 IDPs (83.8%) without an upgrade did as well, and we found no histologic size cutoff that was significant for an upgrade. In the study of Weisman et al, 28 IDPs completely removed in a single core (micropapillomas) showed no upgrade at EXC, and there were no upgrades of 28 fragmented IDPs at EXC. In our study, none of the IDPs with an upgrade were completely removed at CNB, but incomplete removal of the IDP was not predictive of an upgrade. IDP fragmentation in CNB material depends on the size of the IDP, as the mean size of fragmented IDPs in our series was significantly greater that the size of nonfragmented IDPs. It is not possible to determine whether a fragmented IDP is removed completely by CNB. Our data show that neither the IDP histological size in CNB material nor complete IDP removal at CNB predicted an upgrade. IDP fragmentation in CNB material, however, appeared to significantly correlate with an upgrade (P 5.048). All 4 IDPs with an upgrade in our study were fragmented, whereas 77 IDPs (46.1%) without an upgrade were. Histologic evidence of IDP fragmentation in the CNB material might be a factor to consider when one is deciding on the need for EXC, although the high observed frequency of IDP fragmentation in the CNB material limits the utility of this parameter. Li et al 13 reported the presence of microcalcifications detected by CNB histology and imaging to be associated with an upgrade. Our results did not confirm this observation. Information about the extent and severity of the carcinomas found in the EXC specimens of patients with a CNB diagnosis of IDP is scarce. In our study, the upgrade lesions were 2 invasive lobular carcinomas and 2 cases of DCIS, each measuring 2 mm. Three of the carcinomas were away from the residual IDP and did not involve it; this suggests that at least in our cohort, most upgrades were incidental (Table 4). Lewis et al 29 showed that there was no significant increase in the incidence of subsequent ipsilateral breast carcinoma in patients with IDP. The relative risk of developing carcinoma after the identification of IDP in an excisional biopsy specimen was 2.01, which was comparable to the risk in patients with proliferative disease without atypia (1.90). Our study was retrospective and examined the patient population of a cancer hospital at which close imaging surveillance is routinely implemented and diagnostic expertise is readily available. Because of the limited number of cases with an upgrade to carcinoma on EXC in our series, our observations on the association of upgrade to carcinoma with concurrent ipsilateral breast cancer and with evidence of IDP fragmentation on CNB should be regarded as preliminary and hypothesis-generating. Further evaluation of these parameters in relation to an upgrade to carcinoma on EXC in a series with a larger number of upgrades is warranted. Experience in the diagnosis of mammary lesions plays a role in the accuracy of the diagnosis of breast papillary lesions. Jakate et al 30 showed that the upgrade rates of IDP to carcinoma at EXC were different when breast pathologists (2.5%) and non-breast pathologists (6.9%) evaluated the same cases. Our study cases were all reviewed by breast pathologists, and this might account at least in part for the low upgrade rate. Nakhlis et al Cancer September 15, 2016
9 Non-atypical Papillomas Can Be Observed/Pareja et al observed no upgrades at EXC of IDPs diagnosed in radiologic-pathologic concordant CNB samples that were evaluated by an expert breast pathologist. Taken together, our results show that the risk of carcinoma associated with IDP diagnoses in radiologic-pathologic concordant CNB is low. Our data suggest that close radiologic follow-up constitutes appropriate management for these patients. FUNDING SUPPORT The research reported in this publication was supported in part by a Cancer Center Support Grant from the National Institutes of Health/National Cancer Institute (award P30CA008748). CONFLICT OF INTEREST DISCLOSURES The authors made no disclosures. AUTHOR CONTRIBUTIONS Fresia Pareja: Planning of the study, conduct of the study, reporting of the study, and responsibility for the overall content of the study as a guarantor. Adriana D. Corben: Planning of the study, conduct of the study, reporting of the study, and responsibility for the overall content of the study as a guarantor. Sandra B. Brennan: Planning of the study, conduct of the study, and reporting of the study. Melissa P. Murray: Planning of the study, conduct of the study, and reporting of the study. Zenica L. Bowser: Conduct of the study and reporting of the study. Kiran Jakate: Conduct of the study and reporting of the study. Christopher Sebastiano: Conduct of the study and reporting of the study. Monica Morrow: Reporting of the study. Elizabeth A. Morris: Reporting of the study. Edi Brogi: Planning of the study, conduct of the study, reporting of the study, and responsibility for the overall content of the study as a guarantor. REFERENCES 1. MacGrogan G, Tavassoli FA. Central atypical papillomas of the breast: a clinicopathological study of 119 cases. Virchows Arch. 2003; 443: Kil WH, Cho EY, Kim JH, Nam SJ, Yang JH. Is surgical excision necessary in benign papillary lesions initially diagnosed at core biopsy? Breast. 2008;17: Jacobs TW, Connolly JL, Schnitt SJ. Nonmalignant lesions in breast core needle biopsies: to excise or not to excise? Am J Surg Pathol. 2002;26: Renshaw AA, Derhagopian RP, Tizol-Blanco DM, Gould EW. Papillomas and atypical papillomas in breast core needle biopsy specimens: risk of carcinoma in subsequent excision. Am J Clin Pathol. 2004;122: Page DL, Salhany KE, Jensen RA, Dupont WD. Subsequent breast carcinoma risk after biopsy with atypia in a breast papilloma. Cancer. 1996;78: Rizzo M, Linebarger J, Lowe MC, et al. Management of papillary breast lesions diagnosed on core-needle biopsy: clinical pathologic and radiologic analysis of 276 cases with surgical follow-up. JAm Coll Surg. 2012;214: Jung SY, Kang HS, Kwon Y, et al. Risk factors for malignancy in benign papillomas of the breast on core needle biopsy. World J Surg. 2010;34: Shiino S, Tsuda H, Yoshida M, et al. Intraductal papillomas on core biopsy can be upgraded to malignancy on subsequent excisional biopsy regardless of the presence of atypical features. Pathol Int. 2015; 65: Lam WW, Chu WC, Tang AP, Tse G, Ma TK. Role of radiologic features in the management of papillary lesions of the breast. AJR Am J Roentgenol. 2006;186: Nakhlis F, Ahmadiyeh N, Lester S, Raza S, Lotfi P, Golshan M. Papilloma on core biopsy: excision vs. observation. Ann Surg Oncol. 2015;22: Liberman L, Drotman M, Morris EA, et al. Imaging-histologic discordance at percutaneous breast biopsy. Cancer. 2000;89: Swapp RE, Glazebrook KN, Jones KN, et al. Management of benign intraductal solitary papilloma diagnosed on core needle biopsy. Ann Surg Oncol. 2013;20: Li X, Weaver O, Desouki MM, et al. Microcalcification is an important factor in the management of breast intraductal papillomas diagnosed on core biopsy. Am J Clin Pathol. 2012;138: Chang JM, Moon WK, Cho N, et al. Risk of carcinoma after subsequent excision of benign papilloma initially diagnosed with an ultrasound (US)-guided 14-gauge core needle biopsy: a prospective observational study. Eur Radiol. 2010;20: Arora N, Hill C, Hoda SA, Rosenblatt R, Pigalarga R, Tousimis EA. Clinicopathologic features of papillary lesions on core needle biopsy of the breast predictive of malignancy. Am J Surg. 2007;194: Collins LC, Schnitt SJ. Papillary lesions of the breast: selected diagnostic and management issues. Histopathology. 2008;52: Chang JM, Han W, Moon WK, et al. Papillary lesions initially diagnosed at ultrasound-guided vacuum-assisted breast biopsy: rate of malignancy based on subsequent surgical excision. Ann Surg Oncol. 2011;18: Mercado CL, Hamele-Bena D, Singer C, et al. Papillary lesions of the breast: evaluation with stereotactic directional vacuum-assisted biopsy. Radiology. 2001;221: Ahmadiyeh N, Stoleru MA, Raza S, Lester SC, Golshan M. Management of intraductal papillomas of the breast: an analysis of 129 cases and their outcome. Ann Surg Oncol. 2009;16: Skandarajah AR, Field L, Yuen Larn Mou A, et al. Benign papilloma on core biopsy requires surgical excision. Ann Surg Oncol. 2008;15: Glenn ME, Throckmorton AD, Thomison JB III, Bienkowski RS. Papillomas of the breast 15 mm or smaller: 4-year experience in a community-based dedicated breast imaging clinic. Ann Surg Oncol. 2015;22: Cyr AE, Novack D, Trinkaus K, et al. Are we overtreating papillomas diagnosed on core needle biopsy? Ann Surg Oncol. 2011;18: Agoff SN, Lawton TJ. Papillary lesions of the breast with and without atypical ductal hyperplasia: can we accurately predict benign behavior from core needle biopsy? Am J Clin Pathol. 2004;122: Holley SO, Appleton CM, Farria DM, et al. Pathologic outcomes of nonmalignant papillary breast lesions diagnosed at imaging-guided core needle biopsy. Radiology. 2012;265: Wiratkapun C, Keeratitragoon T, Lertsithichai P, Chanplakorn N. Upgrading rate of papillary breast lesions diagnosed by core-needle biopsy. Diagn Interv Radiol. 2013;19: Kim MJ, Kim SI, Youk JH, et al. The diagnosis of non-malignant papillary lesions of the breast: comparison of ultrasound-guided automated gun biopsy and vacuum-assisted removal. Clin Radiol. 2011;66: Jaffer S, Bleiweiss IJ, Nagi C. Incidental intraductal papillomas (<2 mm) of the breast diagnosed on needle core biopsy do not need to be excised. Breast J. 2013;19: Weisman PS, Sutton BJ, Siziopikou KP, et al. Non mass-associated intraductal papillomas: is excision necessary? Hum Pathol. 2014;45: Lewis JT, Hartmann LC, Vierkant RA, et al. An analysis of breast cancer risk in women with single, multiple, and atypical papilloma. Am J Surg Pathol. 2006;30: Jakate K, De Brot M, Goldberg F, Muradali D, O Malley FP, Mulligan AM. Papillary lesions of the breast: impact of breast pathology subspecialization on core biopsy and excision diagnoses. Am J Surg Pathol. 2012;36: Cancer September 15,
Breast Intraductal Papillomas without Atypia in Radiologic-Pathologic Concordant. Core Needle Biopsies: Predictors of Upgrade to Carcinoma at Excision
Page 1 of 28 Breast Intraductal Papillomas without Atypia in Radiologic-Pathologic Concordant Core Needle Biopsies: Predictors of Upgrade to Carcinoma at Excision Fresia Pareja MD PhD 1, *, Adriana Corben
More information3/27/2017. Disclosure of Relevant Financial Relationships. Papilloma???
Management of Papillary Lesions Diagnosed at Rad Path Concordant Core Biopsy (CNB) Disclosure of Relevant Financial Relationships USCAP requires that all planners (Education Committee) in a position to
More informationEnterprise Interest None
Enterprise Interest None B3 lesions of the breast What are they at surgery? Case 4 Edi Brogi MD PhD Attending Pathologist - Director of Breast Pathology Memorial Sloan Kettering Cancer Center New York
More informationAtypical papillary lesions after core needle biopsy and subsequent breast carcinoma
Asian Biomedicine Vol. 5 No. 2 April 2011; 243-248 DOI: 10.5372/1905-7415.0502.031 Original article Atypical papillary lesions after core needle biopsy and subsequent breast carcinoma Tuenchit Khamapirad
More informationAtypical Ductal Hyperplasia and Papillomas: A Comparison of Ultrasound Guided Breast Biopsy and Stereotactic Guided Breast Biopsy
Atypical Ductal Hyperplasia and Papillomas: A Comparison of Ultrasound Guided Breast Biopsy and Stereotactic Guided Breast Biopsy Breast Cancer is the most common cancer diagnosed in women in the United
More informationComparison of Sonographically Guided Core Needle Biopsy and Excision in Breast Papillomas
ORIGINAL RESEARCH Comparison of Sonographically Guided Core Needle Biopsy and Excision in Breast Papillomas Clinical and Sonographic Features Predictive of Malignancy Yu-Mee Sohn, MD, PhD, So Hyun Park,
More informationAnatomic Pathology / Mucocele-like Lesions on Breast Core Biopsy. Mucocele-like Lesions Diagnosed on Breast Core Biopsy
Anatomic Pathology / Mucocele-like Lesions on Breast Core Biopsy Mucocele-like Lesions Diagnosed on Breast Core Biopsy Assessment of Upgrade Rate and Need for Surgical Excision Brian Sutton, MD, 1 Simone
More informationDiagnostic benefits of ultrasound-guided. CNB) versus mammograph-guided biopsy for suspicious microcalcifications. without definite breast mass
Volume 118 No. 19 2018, 531-543 ISSN: 1311-8080 (printed version); ISSN: 1314-3395 (on-line version) url: http://www.ijpam.eu ijpam.eu Diagnostic benefits of ultrasound-guided biopsy versus mammography-guided
More informationExcisional biopsy or long term follow-up results in breast high-risk lesions diagnosed at core needle biopsy
Excisional biopsy or long term follow-up results in breast high-risk lesions diagnosed at core needle biopsy Poster No.: C-2515 Congress: ECR 2015 Type: Authors: Scientific Exhibit Ö. S. Okcu 1, A. Oktay
More informationControversies and Problematic Issues in Core Needle Biopsies (To excise or not to excise)
Controversies and Problematic Issues in Core Needle Biopsies (To excise or not to excise) Laura C. Collins, M.D. Beth Israel Deaconess Medical Center and Harvard Medical School Boston, MA Schematic Representation
More information04/10/2018 HIGH RISK BREAST LESIONS. Pathology Perspectives of High Risk Breast Lesions ELEVATED RISK OF BREAST CANCER HISTORICAL PERSPECTIVES
Pathology Perspectives of High Risk Breast Lesions Savitri Krishnamurthy MD Professor of Pathology Deputy Division Head Director of Clinical Trials, Research and Development The University of Texas MD
More informationTreatment options for the precancerous Atypical Breast lesions. Prof. YOUNG-JIN SUH The Catholic University of Korea
Treatment options for the precancerous Atypical Breast lesions Prof. YOUNG-JIN SUH The Catholic University of Korea Not so benign lesions? Imaging abnormalities(10% recall) lead to diagnostic evaluation,
More informationCNB vs Surgical Excision
Update on Core Needle Biopsy of Non-palpable Breast Lesions Nour Sneige, M.D. UT MD Anderson Cancer Center Houston, Tx Image-Guided CNB of Breast Lesions An alternative to surgical biospy CNB vs Surgical
More informationOriginal Report. Mucocele-Like Tumors of the Breast: Mammographic and Sonographic Appearances. Katrina Glazebrook 1 Carol Reynolds 2
Katrina Glazebrook 1 Carol Reynolds 2 Received January 2, 2002; accepted after revision August 28, 2002. 1 Department of Radiology, Mayo Clinic, 200 First St. S.W., Rochester, MN 55905. Address correspondence
More informationAtypical ductal hyperplasia diagnosed at ultrasound guided biopsy of breast mass
Atypical ductal hyperplasia diagnosed at ultrasound guided biopsy of breast mass Poster No.: C-1483 Congress: ECR 2014 Type: Authors: Keywords: DOI: Scientific Exhibit J. Cho, J. Chung, E. S. Cha, J. E.
More informationProliferative Breast Disease: implications of core biopsy diagnosis. Proliferative Breast Disease
Proliferative Breast Disease: implications of core biopsy diagnosis Jean F. Simpson, M.D. Breast Pathology Consultants, Inc. Nashville, TN Proliferative Breast Disease Must be interpreted in clinical and
More informationFlat Epithelial Atypia
Flat Epithelial Atypia Richard Owings, M.D. University of Arkansas for Medical Sciences Department of Pathology Flat epithelial atypia can be a difficult lesion May be a subtle diagnosis Lots of changes
More informationAdvocating Nonsurgical Management of Patients With Small, Incidental Radial Scars at the Time of Needle Core Biopsy. A Study of 77 Cases
Advocating Nonsurgical Management of Patients With Small, Incidental Radial Scars at the Time of Needle Core Biopsy A Study of 77 Cases Cathleen Matrai, MD; Timothy M. D Alfonso, MD; Lindsay Pharmer, MD;
More informationImaging-Guided Core Needle Biopsy of Papillary Lesions of the Breast
Eric L. Rosen 1 Rex C. Bentley 2 Jay A. Baker 1 Mary Scott Soo 1 Received January 30, 2002; accepted after revision April 12, 2002. 1 Department of Radiology, Breast Imaging Division, Duke University Medical
More informationUnderestimation of Atypical Ductal Hyperplasia at Sonographically Guided Core Biopsy of the Breast
Women s Imaging Original Research Jang et al. Sonographic Breast Biopsy Women s Imaging Original Research WOMEN S IMAGING Underestimation of Atypical Ductal Hyperplasia at Sonographically Guided Core Biopsy
More informationPapillary Lesions of the Breast A Practical Approach to Diagnosis. (Arch Pathol Lab Med. 2016;140: ; doi: /arpa.
Papillary Lesions of the Breast A Practical Approach to Diagnosis (Arch Pathol Lab Med. 2016;140:1052 1059; doi: 10.5858/arpa.2016-0219-RA) Papillary lesions of the breast Span the spectrum of benign,
More informationSonographically-Guided 14-Gauge Core Needle Biopsy for Papillary Lesions of the Breast
Sonographically-Guided 14-Gauge Core Needle Biopsy for Papillary Lesions of the Breast Eun Sook Ko, MD Nariya Cho, MD Joo Hee Cha, MD Jeong Seon Park, MD Sun Mi Kim, MD Woo Kyung Moon, MD Index terms:
More informationTips and Tricks to performing Magnetic Resonance Imaging Guided Breast Interventional Procedures Habib Rahbar, MD, FSBI October 23, 2018, 7:00pm ET
Tips and Tricks to performing Magnetic Resonance Imaging Guided Breast Interventional Procedures Habib Rahbar, MD, FSBI October 23, 2018, 7:00pm ET SAM Questions/Answers/Rationales/References 1. Below
More informationInterpretation of Breast Pathology in the Era of Minimally Invasive Procedures
Shahla Masood, M.D. Professor and Chair Department of Pathology and Laboratory Medicine University of Florida College of Medicine Jacksonville Medical Director, UF Health Breast Center Chief of Pathology
More informationOriginal Article Breast Imaging
Original Article Breast Imaging http://dx.doi.org/10.3348/kjr.2014.15.6.697 pissn 1229-6929 eissn 2005-8330 Korean J Radiol 2014;15(6):697-703 Percutaneous Ultrasound-Guided Vacuum-Assisted Removal versus
More informationThe Role of Percutaneous Biopsy and Prognostic Factors of Malignancy in Solitary Breast Papilloma: A Retrospective Multicenter Study of 259 Cases
The Role of Percutaneous Biopsy and Prognostic Factors of Malignancy in Solitary Breast Papilloma: A Retrospective Multicenter Study of 259 Cases MAUDE LAVAL 1*, ROMAIN DELANGLE 2*, AÏCHA NDOYE 3*, EMMANUELLE
More informationStereotactic 11-Gauge Vacuum- Assisted Breast Biopsy: A Validation Study
Georg Pfarl 1 Thomas H. Helbich 1 Christopher C. Riedl 1 Teresa Wagner 2 Michael Gnant 3 Margaretha Rudas 4 Laura Liberman 5 Received March 11, 2002; accepted after revision May 17, 2002. 1 Department
More informationAtypical proliferative lesions diagnosed on core biopsy - 6 year review
Atypical proliferative lesions diagnosed on core biopsy - 6 year review Dr Angela Harris, Dr Julie Weigner & Dr Ricardo Vilain NSW Health Pathology Pathology North, Hunter Anatomical Pathology & Cytology
More informationUltrasonography-guided 14-gauge core biopsy of the breast: results of 7 years of experience
Ultrasonography-guided 14-gauge core biopsy of the breast: results of 7 years of experience Inha Jung, Min Jung Kim, Hee Jung Moon, Jung Hyun Yoon, Eun-Kyung Kim Department of Radiology and Research Institute
More informationThe Hot Topic for today is a biopsy from a 58-year-old woman who had worrisome mammographic calcifications on screening.
The Hot Topic for today is a biopsy from a 58-year-old woman who had worrisome mammographic calcifications on screening. 1 My name is Dan Visscher; I am a consultant in the Division of Anatomic Pathology
More informationNon-mass Enhancement on Breast MRI. Aditi A. Desai, MD Margaret Ann Mays, MD
Non-mass Enhancement on Breast MRI Aditi A. Desai, MD Margaret Ann Mays, MD Breast MRI Important screening and diagnostic tool, given its high sensitivity for breast cancer detection Breast MRI - Indications
More informationConsensus Guideline on Image-Guided Percutaneous Biopsy of Palpable and Nonpalpable Breast Lesions
Consensus Guideline on Image-Guided Percutaneous Biopsy of Palpable and Nonpalpable Breast Lesions Purpose: To outline the use of minimally invasive biopsy techniques (MIBT) for palpable and nonpalpable
More informationHigh risk lesions of the breast : Review of the current diagnostic and management strategies
High risk lesions of the breast : Review of the current diagnostic and management strategies Poster No.: C-1204 Congress: ECR 2016 Type: Educational Exhibit Authors: P. Jagmohan, F. J. Pool, P. G. Pillay,
More informationDoes Ultrasound-Guided Directional Vacuum-Assisted Removal Help Eliminate Abnormal Nipple Discharge in Patients with Benign Intraductal Single Mass?
Does Ultrasound-Guided Directional Vacuum-Assisted Removal Help Eliminate Abnormal Nipple Discharge in Patients with Benign Intraductal Single Mass? Jung Min Chang, MD 1 Nariya Cho, MD 1 Woo Kyung Moon,
More informationPapillary Lesions of the Breast
Papillary Lesions of the Breast Texas Society of Pathologists 2013 Laura C. Collins, M.D. Associate Professor of Pathology Associate Director, Division of Anatomic Pathology Beth Israel Deaconess Medical
More informationJournal of Breast Cancer
Journal of Breast Cancer ORIGINAL ARTICLE J Breast Cancer 2012 December; 15(4): 407-411 Validation of a Scoring System for Predicting Malignancy in Patients Diagnosed with Atypical Ductal Hyperplasia Using
More informationDisclosures 5/27/2012. Outline of Talk. Outline of Talk. When Is LCIS Clinically Significant? Classic LCIS. Classic LCIS
When Is LCIS Clinically Significant? Disclosures I have nothing to disclose Yunn-Yi Chen, MD, PhD Professor Outline of Talk Outline of Talk Classic LCIS Classic LCIS Definition of lobular differentiation
More informationNational Diagnostic Imaging Symposium 2013 SAM - Breast MRI 1
National Diagnostic Imaging Symposium 2013 December 8-12, 2013 Disney s Yacht Club Resort Lake Buena Vista, Florida Self Assessment Module Questions, Answers and References Day SAM Title - Each SAM title
More informationManagement of B3 lesions
Management of B3 lesions Pathological view Abeer Shaaban Queen Elizabeth Hospital Birmingham FEA AIDP B3 lesions In situ Lobular neoplasia Papilloma Radial scar Fibroaepithelial lesion Mucocoele like lesion
More informationHHS Public Access Author manuscript Am J Surg Pathol. Author manuscript; available in PMC 2016 September 06.
Radial Scar at Image-guided Needle Biopsy: Is Excision Necessary? Niamh Conlon, MB, FRCPath *, Clare D Arcy, MB, FRCPath *, Jennifer B. Kaplan, MD, Zenica L. Bowser, MS *, Anibal Cordero, BS *, Edi Brogi,
More informationSurgical Pathology Issues of Practical Importance
Surgical Pathology Issues of Practical Importance Anne Moore, MD Medical Oncology Syed Hoda, MD Surgical Pathology The pathologist is central to the team approach needed to manage the patient with breast
More informationSurgical Management of High- Risk Breast Lesions
Surgical Management of High- Risk Breast Lesions Amy C. Degnim, MD a, Tari A. King, MD b, * KEYWORDS High-risk lesion Atypical hyperplasia Lobular carcinoma in situ Percutaneous breast biopsy Breast cancer
More informationPapillary Lesions of the Breast: WHO Update
Papillary Lesions of the Breast: WHO Update Stuart J. Schnitt, M.D. Department of Pathology Beth Israel Deaconess Medical Center and Harvard Medical School Boston, MA, USA Papillary Lesions of the Breast
More informationCLINICAL SIGNIFICANCE OF BENIGN EPITHELIAL CHANGES
Papillomas. Papillomas are composed of multiple branching fibrovascular cores, each having a connective tissue axis lined by luminal and myoepithelial cells ( Fig. 23-11 ). Growth occurs within a dilated
More informationPathology of Lobular & Ductal Preneoplasia. Syed A Hoda, MD Weill-Cornell, New York, NY
Pathology of Lobular & Ductal Preneoplasia Syed A Hoda, MD Weill-Cornell, New York, NY Proliferative Epithelial Changes in Breast A wide range of proliferative epithelial changes occur in the breast There
More informationBreast: Difficulties in Core Biopsies
Breast: Difficulties in Core Biopsies Anna Marie Mulligan, MB, MSc, FRCPath University Health Network and University of Toronto E-mail: annamarie.mulligan@uhn.ca No conflicts of interest Role of Core Needle
More informationPapillary Lesions in Breast Pathology Practice: Diagnostic Challenges and Practical Approach. A Six- Year Experience from a Tertiary Care Hospital
Open Access Journal Research Article DOI: 10.23958/ijirms/vol02-i05/12 Papillary Lesions in Breast Pathology Practice: Diagnostic Challenges and Practical Approach. A Six- Year Experience from a Tertiary
More informationLi-Jun Wang 1, Ping Wu 2, Xiao-Xiao Li 1, Ran Luo 1, Deng-Bin Wang 1* and Wen-Bin Guan 3
Wang et al. World Journal of Surgical Oncology (2018) 16:234 https://doi.org/10.1186/s12957-018-1537-9 RESEARCH Open Access Magnetic resonance imaging features for differentiating breast papilloma with
More informationThe Ratio of Atypical Ductal Hyperplasia Foci to Core Numbers in Needle Biopsy: A Practical Index Predicting Breast Cancer in Subsequent Excision
The Korean Journal of Pathology 2012; 46: 15-21 ORIGINAL ARTICLE The Ratio of Atypical Ductal Hyperplasia Foci to Core Numbers in Needle Biopsy: A Practical Index Predicting Breast Cancer in Subsequent
More informationMichael J. Wagoner, MD, 1 Christine Laronga, MD, 2 and Geza Acs, MD, PhD 1-3. Abstract
Anatomic Pathology / ADH in Breast Core Needle Biopsy Specimens Extent and Histologic Pattern of Atypical Ductal Hyperplasia Present on Core Needle Biopsy Specimens of the Breast Can Predict Ductal Carcinoma
More informationRadiologic Findings of Mucocele-like Tumors of the breast: Can we differentiate pure benign from associated with high risk lesions?
Radiologic Findings of Mucocele-like Tumors of the breast: Can we differentiate pure benign from associated with high risk lesions? Poster No.: C-0332 Congress: ECR 2014 Type: Educational Exhibit Authors:
More informationEpithelial Columnar Breast Lesions: Histopathology and Molecular Markers
29th Annual International Conference Advances in the Application of Monoclonal Antibodies in Clinical Oncology and Symposium on Cancer Stem Cells 25 th -27t h June, 2012, Mykonos, Greece Epithelial Columnar
More informationCase study 1. Rie Horii, M.D., Ph.D. Division of Pathology Cancer Institute Hospital, Japanese Foundation for Cancer Research
NCCN/JCCNB Seminar in Japan April 15, 2012 Case study 1 Rie Horii, M.D., Ph.D. Division of Pathology Cancer Institute Hospital, Japanese Foundation for Cancer Research Present illness: A 50y.o.premenopausal
More informationMammographic features and correlation with biopsy findings using 11-gauge stereotactic vacuum-assisted breast biopsy (SVABB)
Original article Annals of Oncology 14: 450 454, 2003 DOI: 10.1093/annonc/mdh088 Mammographic features and correlation with biopsy findings using 11-gauge stereotactic vacuum-assisted breast biopsy (SVABB)
More informationQuality ID #263: Preoperative Diagnosis of Breast Cancer National Quality Strategy Domain: Effective Clinical Care
Quality ID #263: Preoperative Diagnosis of Breast Cancer National Quality Strategy Domain: Effective Clinical Care 2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY MEASURE TYPE: Process DESCRIPTION:
More informationGuidance on the management of B3 lesions
Guidance on the management of B3 lesions Lesion diagnosed on 14g or vacuumassisted biopsy (VAB) Risk of upgrade Recommended investigation Suggested approach for follow-up if no malignancy on VAE awaiting
More informationUtility of Adequate Core Biopsy Samples from Ultrasound Biopsies Needed for Today s Breast Pathology
Utility of Adequate Core Biopsy Samples from Ultrasound Biopsies Needed for Today s Breast Pathology Ugur Ozerdem, M.D. 1 Abstract Background: There is a paradigm shift in breast biopsy philosophy. In
More informationJournal of Breast Cancer
Journal of Breast Cancer ORIGINAL ARTICLE J Breast Cancer 2014 September; 17(3): 265-269 Absence of Residual Microcalcifications in Atypical Ductal Hyperplasia Diagnosed via Stereotactic Vacuum-Assisted
More informationEARLY DETECTION: MAMMOGRAPHY AND SONOGRAPHY
EARLY DETECTION: MAMMOGRAPHY AND SONOGRAPHY Elizabeth A. Rafferty, M.D. Avon Comprehensive Breast Center Massachusetts General Hospital Harvard Medical School Breast Cancer Screening Early detection of
More informationDuctal Carcinoma in Situ. Laura C. Collins, M.D. Department of Pathology Beth Israel Deaconess Medical Center and Harvard Medical School Boston, MA
Ductal Carcinoma in Situ Laura C. Collins, M.D. Department of Pathology Beth Israel Deaconess Medical Center and Harvard Medical School Boston, MA Definition of DCIS WHO 2012 A neoplastic proliferation
More informationColumnar Cell Lesions
Columnar Cell Lesions Laura C. Collins, M.D. Department of Pathology Beth Israel Deaconess Medical Center and Harvard Medical School Boston, MA Question? Columnar cell lesions are: a) Annoying lesions
More informationBenign Breast Disease and Breast Cancer Risk
Benign Breast Disease and Breast Cancer Risk Jean F. Simpson, M.D. Vanderbilt University Nashville, Tennessee December 1, 2011 Nashville Nashville Lebanon 1 Cedars of Lebanon State Park The American University
More informationCystic Hypersecretory Carcinoma of the Breast:
J Korean Soc Radiol 2010;62:287-294 Cystic Hypersecretory Carcinoma of the Breast: Sonographic Features with a Histological Correlation 1 Sang Yu Nam, M.D., Boo-Kyung Han, M.D., Jung Hee Shin, M.D., Eun
More informationRSNA, /radiol Appendix E1. Methods
RSNA, 2016 10.1148/radiol.2016151097 Appendix E1 Methods US and Near-infrared Data Acquisition Four optical wavelengths (740 nm, 780 nm, 808 nm, and 830 nm) were used to sequentially deliver the light
More informationLobular Carcinoma In Situ Variants in Breast Cores
Lobular Carcinoma In Situ Variants in Breast Cores Potential for Misdiagnosis, Upgrade Rates at Surgical Excision, and Practical Implications Megan E. Sullivan, MD; Seema A. Khan, MD; Yurdanur Sullu, MD;
More informationAtypical Ductal Hyperplasia and Ductal Carcinoma In Situ as Revealed by Large-Core Needle Breast Biopsy: Results of Surgical Excision
Marla L. Rosenfield Darling 1 Darrell N. Smith 1 Susan C. Lester 2 Carolyn Kaelin 3 Donna-Lee G. Selland 1 Christine M. Denison 1 Pamela J. DiPiro 1 David I. Rose 1 Esther Rhei 3 Jack E. Meyer 1 Received
More informationCytyc Corporation - Case Presentation Archive - March 2002
FirstCyte Ductal Lavage History: 68 Year Old Female Gail Index: Unknown Clinical History: Negative Mammogram in 1995 6 yrs. later presents with bloody nipple discharge Subsequent suspicious mammogram Suspicious
More informationSonographically Guided Core Biopsy of the Breast: Comparison of 14-Gauge Automated Gun and 11-Gauge Directional Vacuum-Assisted Biopsy Methods
Sonographically Guided Core Biopsy of the Breast: Comparison of 14-Gauge Automated Gun and 11-Gauge Directional Vacuum-Assisted Biopsy Methods Nariya Cho, MD 1 Woo Kyung Moon, MD 1 Joo Hee Cha, MD 1 Sun
More informationRadiologic and pathologic correlation of non-mass like breast lesions on US and MRI: Benign, high risk, versus malignant
Radiologic and pathologic correlation of non-mass like breast lesions on US and MRI: Benign, high risk, versus malignant Poster No.: C-1161 Congress: ECR 2013 Type: Educational Exhibit Authors: J. Kwak,
More informationRadiologic and pathologic correlation of non-mass like breast lesions on US and MRI: Benign, high risk, versus malignant
Radiologic and pathologic correlation of non-mass like breast lesions on US and MRI: Benign, high risk, versus malignant Poster No.: C-1161 Congress: ECR 2013 Type: Educational Exhibit Authors: J. Kwak,
More informationEARLY DETECTION: MAMMOGRAPHY AND SONOGRAPHY
EARLY DETECTION: MAMMOGRAPHY AND SONOGRAPHY Elizabeth A. Rafferty, M.D. Avon Comprehensive Breast Center Massachusetts General Hospital Harvard Medical School Breast Cancer Screening Early detection of
More informationMammographic imaging of nonpalpable breast lesions. Malai Muttarak, MD Department of Radiology Chiang Mai University Chiang Mai, Thailand
Mammographic imaging of nonpalpable breast lesions Malai Muttarak, MD Department of Radiology Chiang Mai University Chiang Mai, Thailand Introduction Contents Mammographic signs of nonpalpable breast cancer
More informationIntraductal Mass on Breast Ultrasound: Final Outcomes and Predictors of Malignancy
Women s Imaging Original Research Kim et al. Intraductal Mass on Breast Ultrasound Women s Imaging Original Research Won Hwa Kim 1 Jung Min Chang 1 Woo Kyung Moon 1 Nariya Cho 1 Ann Yi 2 Hye Ryoung Koo
More informationManagement of Patients Diagnosed With Lobular Carcinoma in Situ at Needle Core Biopsy at a Community-Based Outpatient Facility
Women s Imaging Original Research Destounis et al. Management of LCIS Diagnosed at Core Needle Biopsy Women s Imaging Original Research FOCUS ON: Stamatia V. Destounis 1 Philip F. Murphy Posy J. Seifert
More informationPalpable Breast Lesions Cytomorphological Analysis and Scoring System with Histopatholgical Correlation
IOSR Journal of Dental and Medical Sciences (IOSR-JDMS) e-issn: 2279-0853, p-issn: 2279-0861.Volume 15, Issue 10 Ver. III (October. 2016), PP 25-29 www.iosrjournals.org Palpable Breast Lesions Cytomorphological
More informationClassic lobular neoplasia on core biopsy: a clinical and radio-pathologic correlation study with follow-up excision biopsy
762 & 2013 USCAP, Inc All rights reserved 0893-3952/13 $32.00 Classic lobular neoplasia on core biopsy: a clinical and radio-pathologic correlation study with follow-up excision biopsy Shweta Chaudhary
More informationControversies on the Management of High Risk Breast Lesions on Core Biopsy: An Update on the Literature
Controversies on the Management of High Risk Breast Lesions on Core Biopsy: An Update on the Literature Dianne Georgian- Smith MD Brigham and Women s Hospital Associate Professor of Radiology, Harvard
More informationPitfalls and Limitations of Breast MRI. Susan Orel Roth, MD Professor of Radiology University of Pennsylvania
Pitfalls and Limitations of Breast MRI Susan Orel Roth, MD Professor of Radiology University of Pennsylvania Objectives Review the etiologies of false negative breast MRI examinations Discuss the limitations
More informationPapillary Lesions of the Breast
Papillary Lesions of the Breast Laura C. Collins, M.D. Associate Professor of Pathology Associate Director, Division of Anatomic Pathology Beth Israel Deaconess Medical Center and Harvard Medical School
More informationBI-RADS CATEGORIZATION AND BREAST BIOPSY categorization in the selection of appropriate breast biopsy technique is also discussed. Patients and method
Original Article Positive Predictive Value of BI-RADS Categorization in an Asian Population Yah-Yuen Tan, Siew-Bock Wee, Mona P.C. Tan and Bee-Kiang Chong, 1 Departments of General Surgery and 1Diagnostic
More informationThe management of B3 lesions with emphasis on lobular neoplasia
The management of B3 lesions with emphasis on lobular neoplasia Abeer Shaaban Queen Elizabeth Hospital Birmingham NHSBSP core biopsy categories B1 - Normal B2 - Benign B3 Uncertain malignant potential
More informationProliferative Epithelial lesions of the Breast. Sami Shousha, MD, FRCPath Charing Cross Hospital & Imperial College, London
Proliferative Epithelial lesions of the Breast Sami Shousha, MD, FRCPath Charing Cross Hospital & Imperial College, London Amman, November2013 Proliferative Epithelial Lesions of the Breast Usual type
More informationBreast Lesion Excision System-Intact (BLES): A Stereotactic Method of Biopsy of Suspicius Non-Palpable Mammographic Lesions.
Breast Lesion Excision System-Intact (BLES): A Stereotactic Method of Biopsy of Suspicius Non-Palpable Mammographic Lesions. Poster No.: C-1595 Congress: ECR 2014 Type: Authors: Scientific Exhibit I. Georgiou
More informationPathologic outcomes of coarse heterogeneous calcifications detected on mammography
Pathologic outcomes of coarse heterogeneous calcifications detected on mammography Poster No.: C-1957 Congress: ECR 2011 Type: Scientific Paper Authors: H. J. Lim, K. R. Cho, K. W. Hwang, B. K. Seo, O.
More informationFollow-up of breast papillary lesion on core needle biopsy: experience in African-American population
Wang et al. Diagnostic Pathology 2014, 9:86 RESEARCH Open Access Follow-up of breast papillary lesion on core needle biopsy: experience in African-American population He Wang 1*, Patricia Tsang 2, Cyril
More informationIBCM 2, April 2009, Sarajevo, Bosnia and Herzegovina
Preoperative diagnosis and treatment planning in breast cancer The pathologist s perspective L. Mazzucchelli Istituto Cantonale di Patologia Locarno, Switzerland IBCM 2, 23-25 April 2009, Sarajevo, Bosnia
More informationVacuum-assisted breast biopsy using computer-aided 3.0 T- MRI guidance: diagnostic performance in 173 lesions
Vacuum-assisted breast biopsy using computer-aided 3.0 T- MRI guidance: diagnostic performance in 173 lesions Poster No.: C-2870 Congress: ECR 2017 Type: Scientific Exhibit Authors: A. Pozzetto, L. Camera,
More informationDiagnostic accuracy of ultrasonography-guided core needle biopsy for breast lesions
Singapore Med J 01; 5(1) 40 Diagnostic accuracy of ultrasonography-guided core needle biopsy for breast lesions Wiratkapun Cl, MD, Treesit T1, MD, Wibulpolprasert E1, MD, Lertsithichai P, MD, MSc INTRODUCTION
More informationSignificance of flat epithelial atypia on mammotome core needle biopsy: should it be excised? B
Human Pathology (2007) 38, 35 41 www.elsevier.com/locate/humpath Original contribution Significance of flat epithelial atypia on mammotome core needle biopsy: should it be excised? B Lakshmi P. Kunju MD,
More informationDuctal Proliferations of the Breast: The Good, the Bad, and the Ugly
Ductal Proliferations of the Breast: The Good, the Bad, and the Ugly Melinda F. Lerwill, MD CRITERIA FOR DISTINGUISHING LOW-GRADE DUCTAL CARCINOMA IN SITU FROM USUAL DUCTAL HYPERPLASIA CYTOLOGY Low-grade
More informationAtypical Ductal Hyperplasia of the Breast:
Atypical Ductal Hyperplasia of the Breast: Radiologic and Histopathologic Correlation 1 Ji Young Lee, M.D., Bo Kyoung Seo, M.D. 2, Jung Hyck Kim, M.D., Yu Whan Oh, M.D., Kyu Ran Cho, M.D., Eun Jeong Choi,
More informationWomen s Imaging Original Research
Women s Imaging Original Research Villa et al. Biopsy of Atypical Ductal Hyperplasia Women s Imaging Original Research WOMEN S IMAGING Alessandro Villa 1 Alberto Tagliafico 2 Fabio Chiesa 1 Maurizio Chiaramondia
More informationClinician s Guide to Imaging and Pathologic Findings in Benign Breast Disease. Lonzetta Neal, MD; Cindy L. Tortorelli, MD; and Aziza Nassar, MD
CONCISE REVIEW FOR CLINICIANS GUIDE TO IMAGING AND PATHOLOGIC FINDINGS IN BENIGN BREAST DISEASE Clinician s Guide to Imaging and Pathologic Findings in Benign Breast Disease Lonzetta Neal, MD; Cindy L.
More informationIncidence and Management of Complex Fibroadenomas
Incidence and Management of Complex Fibroadenomas Women s Imaging Original Research 214.fm 11/29/07 WOMEN S IMAGING Miri Sklair-Levy 1 Tamar Sella 1 Tanir Alweiss 2 Ilia Craciun 1 Eugene Libson 1 Bella
More informationPapillary lesions of the breast: selected diagnostic and management issues
Histopathology 2008, 52, 20 29. DOI: 10.1111/j.1365-2559.2007.02898.x REVIEW Papillary lesions of the breast: selected diagnostic and management issues L C Collins & S J Schnitt Department of Pathology,
More informationTriple Negative Breast Cancer: Clinical Presentation and Multimodality Imaging Characteristics
Triple Negative Breast Cancer: Clinical Presentation and Multimodality Imaging Characteristics Poster No.: R-0141 Congress: RANZCR-AOCR 2012 Type: Scientific Exhibit Authors: O. H. Woo, S. Jang, K. R.
More informationImage guided core biopsies:
Recommendations on the Surgical, Radiologic and Pathologic Approaches to Breast Disease: Using best practices based on multidisciplinary methodologies developed through the Allina Breast Committee. Image
More informationMacrobiopsy under X-Ray Guidance
Macrobiopsy under X-Ray Guidance C. Balleyguier, B. Boyer Radiology Gustave Roussy, Villejuif, France Breast Intervention Imaging Major domain in breast imaging European guidelines recommend a pre surgical
More informationPapillary Lesions of the Breast: MRI, Ultrasound, and Mammographic Appearances
Women s Imaging Pictorial Essay Eiada et al. Imaging Papillary Lesions of the reast Women s Imaging Pictorial Essay Downloaded from www.ajronline.org by 37.44.198.194 on 01/27/18 from IP address 37.44.198.194.
More information